• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An overview of the national immunization policy making process: the role of the Korea expert committee on immunization practices.国家免疫政策制定过程概述:韩国免疫实践专家委员会的作用。
Korean J Pediatr. 2012 Jan;55(1):1-5. doi: 10.3345/kjp.2012.55.1.1. Epub 2012 Jan 31.
2
Expert Consensus on the Structure, Role, and Procedures of the Korea Expert Committee on Immunization Practices.韩国免疫实践专家委员会的结构、角色和程序的专家共识。
J Korean Med Sci. 2024 Jun 3;39(21):e166. doi: 10.3346/jkms.2024.39.e166.
3
Immunization decision-making in the Republic of Korea: the structure and functioning of the Korea Advisory Committee on Immunization Practices.韩国的免疫决策:韩国免疫实践咨询委员会的结构和运作。
Vaccine. 2010 Apr 19;28 Suppl 1:A91-5. doi: 10.1016/j.vaccine.2010.02.040.
4
The role of National Immunization Technical Advisory Groups (NITAG) in strengthening health system governance: Lessons from three middle-income countries-Argentina, Jordan, and South Africa (2017-2018).国家免疫技术咨询小组(NITAG)在加强卫生系统治理中的作用:来自阿根廷、约旦和南非三个中等收入国家的经验教训(2017-2018 年)。
Vaccine. 2020 Oct 21;38(45):7118-7128. doi: 10.1016/j.vaccine.2020.08.069. Epub 2020 Sep 16.
5
Supporting National Immunization Technical Advisory Groups (NITAGs) in development of evidence-based vaccine recommendations and NITAG assessments - New tools and approaches.支持国家免疫技术咨询小组(NITAGs)制定基于证据的疫苗建议和NITAG评估——新工具和方法。
Vaccine. 2024 Oct 24;42 Suppl 4(Suppl 4):125610. doi: 10.1016/j.vaccine.2024.01.035. Epub 2024 Jan 24.
6
Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health's Partnership for influenza vaccine introduction.支持资源有限环境下的国家免疫技术咨询小组(NITAGs)。全球卫生行动专家组在流感疫苗引入方面的新策略和经验教训。
Vaccine. 2019 Jun 19;37(28):3646-3653. doi: 10.1016/j.vaccine.2019.05.046. Epub 2019 May 23.
7
The National Immunization Technical Advisory Group in Israel.以色列国家免疫技术咨询小组。
Isr J Health Policy Res. 2021 Jan 26;10(1):7. doi: 10.1186/s13584-021-00442-4.
8
Implementing efficient and sustainable collaboration between National Immunization Technical Advisory Groups: Report on the 3rd International Technical Meeting, Paris, France, 8-9 December 2014.在国家免疫技术咨询小组之间开展高效且可持续的合作:2014年12月8 - 9日于法国巴黎召开的第三届国际技术会议报告
Vaccine. 2016 Mar 8;34(11):1325-30. doi: 10.1016/j.vaccine.2016.01.063. Epub 2016 Feb 6.
9
Moving forward on strengthening and sustaining National Immunization Technical Advisory Groups (NITAGs) globally: Recommendations from the 2nd global NITAG network meeting.推进全球强化和维持国家免疫技术咨询小组(NITAGs):第二届全球 NITAG 网络会议的建议。
Vaccine. 2017 Dec 15;35(50):6925-6930. doi: 10.1016/j.vaccine.2017.10.048. Epub 2017 Nov 2.
10
Value and effectiveness of National Immunization Technical Advisory Groups in low- and middle-income countries: a qualitative study of global and national perspectives.国家免疫技术咨询小组在中低收入国家的价值和效果:全球和国家观点的定性研究。
Health Policy Plan. 2019 May 1;34(4):271-281. doi: 10.1093/heapol/czz027.

引用本文的文献

1
Expert Consensus on the Structure, Role, and Procedures of the Korea Expert Committee on Immunization Practices.韩国免疫实践专家委员会的结构、角色和程序的专家共识。
J Korean Med Sci. 2024 Jun 3;39(21):e166. doi: 10.3346/jkms.2024.39.e166.
2
National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.国家决策引进新疫苗:系统评价,2010-2020 年。
Vaccine. 2021 Apr 1;39(14):1897-1909. doi: 10.1016/j.vaccine.2021.02.059. Epub 2021 Mar 6.

本文引用的文献

1
Immunization decision-making in the Republic of Korea: the structure and functioning of the Korea Advisory Committee on Immunization Practices.韩国的免疫决策:韩国免疫实践咨询委员会的结构和运作。
Vaccine. 2010 Apr 19;28 Suppl 1:A91-5. doi: 10.1016/j.vaccine.2010.02.040.
2
The structure, role, and procedures of the U.S. Advisory Committee on Immunization Practices (ACIP).美国免疫实践咨询委员会(ACIP)的结构、作用和程序。
Vaccine. 2010 Apr 19;28 Suppl 1:A68-75. doi: 10.1016/j.vaccine.2010.02.037.
3
Canada's National Advisory Committee on Immunization (NACI): evidence-based decision-making on vaccines and immunization.加拿大免疫咨询委员会(NACI):疫苗和免疫接种的循证决策。
Vaccine. 2010 Apr 19;28 Suppl 1:A58-63. doi: 10.1016/j.vaccine.2010.02.035.
4
The United Kingdom Joint Committee on Vaccination and Immunisation.英国疫苗接种和免疫联合委员会。
Vaccine. 2010 Apr 19;28 Suppl 1:A54-7. doi: 10.1016/j.vaccine.2010.02.034.
5
National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening.国家免疫技术咨询专家组(NITAGs):建立和加强其指导原则。
Vaccine. 2010 Apr 19;28 Suppl 1:A18-25. doi: 10.1016/j.vaccine.2010.02.027.
6
A global look at national Immunization Technical Advisory Groups.全球视角下的国家免疫技术咨询小组。
Vaccine. 2010 Apr 19;28 Suppl 1:A13-7. doi: 10.1016/j.vaccine.2009.07.089.

国家免疫政策制定过程概述:韩国免疫实践专家委员会的作用。

An overview of the national immunization policy making process: the role of the Korea expert committee on immunization practices.

作者信息

Cho Hee Yeon

机构信息

Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Korean J Pediatr. 2012 Jan;55(1):1-5. doi: 10.3345/kjp.2012.55.1.1. Epub 2012 Jan 31.

DOI:10.3345/kjp.2012.55.1.1
PMID:22359523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3282212/
Abstract

The need for evidence-based decision making in immunization programs has increased due to the presence of multiple health priorities, limited human resources, expensive vaccines, and limited funds. Countries should establish a group of national experts to advise their Ministries of Health. So far, many nations have formed their own National Immunization Technical Advisory Groups (NITAGs). In the Republic of Korea, the Korea Expert Committee on Immunization Practices (KECIP), established by law in the early 1990s, has made many important technical recommendations to contribute to the decline in vaccine preventable diseases and currently functions as a NITAG. It includes 13 core members and 2 non-core members, including a chairperson. Core members usually come from affiliated organizations in internal medicine, pediatrics, obstetrics, microbiology, preventive medicine, nursing and a representative from a consumer group, all of whom serve two year terms. Non-core members comprise two government officials belonging to the Korea Centers for Disease Control and Prevention (KCDC) and the Korea Food and Drug Administration. Meetings are held as needed, but at least twice a year, and sub-committees are formed as a resource for gathering, analyzing, and preparing information for the KECIP meetings. Once the sub-committees or the KCDC review the available data, the KECIP members discuss each issue in depth and develop recommendations, usually by a consensus in the meeting. The KECIP publishes national guidelines and immunization schedules that are updated regularly. KECIP's role is essentially consultative and the implementation of their recommendations may depend on the budget or current laws.

摘要

由于存在多个卫生重点事项、人力资源有限、疫苗昂贵以及资金有限,免疫规划中基于证据的决策需求有所增加。各国应设立一组国家专家,为其卫生部提供建议。到目前为止,许多国家已经组建了自己的国家免疫技术咨询小组(NITAGs)。在大韩民国,20世纪90年代初依法设立的韩国免疫实践专家委员会(KECIP),为疫苗可预防疾病的减少做出了许多重要技术建议,目前作为一个NITAG发挥作用。它包括13名核心成员和2名非核心成员,包括一名主席。核心成员通常来自内科、儿科、产科、微生物学、预防医学、护理等附属机构以及一名消费者团体代表,他们的任期均为两年。非核心成员包括两名隶属于韩国疾病控制与预防中心(KCDC)和韩国食品药品管理局的政府官员。会议根据需要召开,但每年至少两次,并成立小组委员会,作为为KECIP会议收集、分析和准备信息的资源。一旦小组委员会或KCDC审查了现有数据,KECIP成员就会深入讨论每个问题并制定建议,通常在会议上以协商一致的方式进行。KECIP发布定期更新的国家指南和免疫规划时间表。KECIP的作用本质上是咨询性的,其建议的实施可能取决于预算或现行法律。